“…Short-term outcomes were available for only six studies: no patient died in the first 7-10 days, seven patients had recurrent VTE and two experienced major bleeding [20,22,[29][30][31][32]. Data on the long-term outcome were available for nine out of the 11 studies [9,19,22,27,29,31,32,35,37].…”